These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26983250)

  • 1. [Study and Evaluation on Preparation of Monolithic Osmotic Pump Tablet of Resveratrol].
    Wu XC; Hao HJ; Song XY; Zhang YZ; Liu YX; Zhang HQ
    Zhong Yao Cai; 2015 Aug; 38(8):1732-5. PubMed ID: 26983250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation design and characterization of an elementary osmotic pump tablet of flurbiprofen.
    Patel KN; Mehta TA
    PDA J Pharm Sci Technol; 2014; 68(4):333-46. PubMed ID: 25035256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubility-modulated monolithic osmotic pump tablet for atenolol delivery.
    Liu L; Wang X
    Eur J Pharm Biopharm; 2008 Feb; 68(2):298-302. PubMed ID: 17560099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and
    Li N; Fan L; Wu B; Dai G; Jiang C; Guo Y; Wang D
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1079-1088. PubMed ID: 30909753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preparation and Synchronized Release Behavior on Porosity Osmotic Pump Tablets of Total Glucosides of Paeony].
    Wu XC; Hao HJ; Song XY; Liu YX; Zhang YZ; Zhang HQ
    Zhong Yao Cai; 2016 Feb; 39(2):363-6. PubMed ID: 30080371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production and
    Ma C; Huang Z; Zhu Y; Chen X; Singh V; Huang Y; Pan X; Wu C
    Pharmazie; 2017 Sep; 72(9):511-517. PubMed ID: 29441977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled release of glaucocalyxin - a self-nanoemulsifying system from osmotic pump tablets with enhanced bioavailability.
    Yanfei M; Guoguang C; Lili R; Pingkai O
    Pharm Dev Technol; 2017 Mar; 22(2):148-155. PubMed ID: 26400477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preparation of atenolol monolithic osmotic pump tablets].
    Liu LX; Che BJ; Xu Q
    Yao Xue Xue Bao; 2006 May; 41(5):457-60. PubMed ID: 16848324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and evaluation of osmotic pump-based controlled release system of Ambroxol Hydrochloride.
    Cheng X; Sun M; Gao Y; Cao F; Zhai G
    Pharm Dev Technol; 2011 Aug; 16(4):392-9. PubMed ID: 20429827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of monolithic osmotic pump system by coating the indented core tablet.
    Liu L; Che B
    Eur J Pharm Biopharm; 2006 Oct; 64(2):180-4. PubMed ID: 16797951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synchronous delivery of felodipine and metoprolol tartrate using monolithic osmotic pump technology.
    Zhao S; Yu F; Liu N; Di Z; Yan K; Liu Y; Li Y; Zhang H; Yang Y; Yang Z; Li Z; Mei X
    Drug Dev Ind Pharm; 2016 Nov; 42(11):1723-31. PubMed ID: 27074758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of bilayer-core osmotic pump tablet by coating the indented core tablet.
    Liu L; Xu X
    Int J Pharm; 2008 Mar; 352(1-2):225-30. PubMed ID: 18068918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zero-order release and bioavailability enhancement of poorly water soluble Vinpocetine from self-nanoemulsifying osmotic pump tablet.
    El-Zahaby SA; AbouGhaly MHH; Abdelbary GA; El-Gazayerly ON
    Pharm Dev Technol; 2018 Nov; 23(9):900-910. PubMed ID: 28540754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled release of ziprasidone solid dispersion systems from osmotic pump tablets with enhanced bioavailability in the fasted state.
    Yanfei M; Guoguang C; Lili R; Pingkai O
    Drug Dev Ind Pharm; 2015; 41(8):1353-62. PubMed ID: 25138348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The delivery mechanism of micro-porous osmotic pump tablets].
    Zhao XL; Li Q; Gong XF; Li SM
    Yao Xue Xue Bao; 2007 Feb; 42(2):226-30. PubMed ID: 17518057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monolithic osmotic tablet containing solid dispersion of 10-hydroxycamptothecin.
    Chen H; Jiang G; Ding F
    Drug Dev Ind Pharm; 2009 Feb; 35(2):131-7. PubMed ID: 19169941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Evaluation of High Bioavailable Sustained-Release Nimodipine Tablets Prepared with Monolithic Osmotic Pump Technology.
    Kong H; Yu F; Liu Y; Yang Y; Li M; Cheng X; Hu X; Tang X; Li Z; Mei X
    Curr Drug Deliv; 2018; 15(1):44-51. PubMed ID: 27834149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of prazosin hydrochloride from osmotic pump system prepared by coating the core tablet with an indentation.
    Liu L; Wang J; Zhu S
    Drug Deliv; 2007 Apr; 14(4):219-24. PubMed ID: 17497354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monolithic osmotic tablet system for nifedipine delivery.
    Liu L; Khang G; Rhee JM; Lee HB
    J Control Release; 2000 Jul; 67(2-3):309-22. PubMed ID: 10825563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel osmotic pump tablet using core of drug-resin complexes for time-controlled delivery system.
    Wang C; Chen F; Li JZ; Tang H; Li X; Yan KS; Ye GH; Pan WS
    Yakugaku Zasshi; 2008 May; 128(5):773-82. PubMed ID: 18451626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.